Company intelligence / Profile preview

Diagnostic BioSystems

Pleasanton, California, United Statesdbiosys.com ↗

Ownership: Private
Development stage: Commercial

Overview

Diagnostic BioSystems offers a broad portfolio of commercialized in vitro diagnostic reagents and automated systems for immunohistochemistry and anatomic pathology. Their products are used globally in clinical laboratories for cancer diagnosis and research. They have launched several innovative antibodies, detection kits, autostainers, including the Montage360 Autostainer and HighLighter Automated Staining System. The company has expanded internationally with offices in Mexico City, Hyderabad (India), and Germany.

Therapeutic areas: Oncology
Modalities: AntibodyMonoclonal antibodyFluorescent antibody (FITC conjugated)Device (Automated stainers and platforms)Detection kit (for immunohistochemistry/anatomic pathology)Chromogen reagent kits
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Diagnostic BioSystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnostic BioSystems.

Explore the full profile